Galectin-3 License And Distribution Agreement Sample Contracts

Confidential Galectin-3 License and Distribution Agreement (February 3rd, 2011)

This GALECTIN -3 LICENSE AND DISTRIBUTION AGREEMENT (this Agreement), entered into as of December 14, 2010 (the Effective Date), by and between Siemens Healthcare Diagnostics Inc, a corporation of the state of California, having its principal place of business at 511 Benedict Avenue, Tarrytown, NY 10591 (SIEMENS) and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610N Lincoln Street, Waltham, MA 02451 (BGM).

Confidential Galectin-3 License and Distribution Agreement (February 1st, 2011)

This GALECTIN -3 LICENSE AND DISTRIBUTION AGREEMENT (this Agreement), entered into as of December 14, 2010 (the Effective Date), by and between Siemens Healthcare Diagnostics Inc, a corporation of the state of California, having its principal place of business at 511 Benedict Avenue, Tarrytown, NY 10591 (SIEMENS) and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610N Lincoln Street, Waltham, MA 02451 (BGM).

Confidential Galectin-3 License and Distribution Agreement (November 8th, 2010)

This GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENT (this Agreement), entered into as of March 19, 2010 (the Effective Date), by and between Inverness Medical Innovations, Inc., a corporation of the state of Delaware, having its principal place of business at 51 Sawyer Road, Suite 200, Waltham, MA 02453 (IMI) and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610 Lincoln Street North Waltham, MA 02451 (BGM).

Confidential Galectin-3 License and Distribution Agreement (November 8th, 2010)

This GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENT (this Agreement), entered into as of May 29, 2010 (the Effective Date), by and between bioMerieux SA, a Societe Anonyme (corporation) organized under the laws of France having its principal place of business at Chemin de lOrme, 69280 Marcy lEtoile, France (BMX). and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610 Lincoln Street North Waltham, MA 02451 (BGM).

Confidential Galectin-3 License and Distribution Agreement (August 31st, 2010)

This GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENT (this Agreement), entered into as of November 11, 2009 (the Effective Date), by and between Abbott Laboratories, a corporation of the state of Illinois, having its principal place of business at 100 Abbott Park Road, Abbott Park, IL 60064-3500 (Abbott) and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610 Lincoln Street North Waltham, MA 02451 (BGM).

Confidential First Amendment to Galectin-3 License and Distribution Agreement (March 12th, 2010)

THIS FIRST AMENDMENT TO GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENT (this First Amendment) is entered into as of February 3, 2010 (the First Amendment Date) by and between Abbott Laboratories, a corporation of the state of Illinois, having its principal place of business at 100 Abbott Park Road, Abbott Park, Illinois 60064-3500 (Abbott) and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610 Lincoln Street North, Waltham, Massachusetts 02451 (BGM).

Confidential Galectin-3 License and Distribution Agreement (February 12th, 2010)

This GALECTIN-3 LICENSE AND DISTRIBUTION AGREEMENT (this Agreement), entered into as of November 11, 2009 (the Effective Date), by and between Abbott Laboratories, a corporation of the state of Illinois, having its principal place of business at 100 Abbott Park Road, Abbott Park, IL 60064-3500 (Abbott) and BG Medicine, Inc., a corporation of the state of Delaware, having its principal place of business at 610 Lincoln Street North Waltham, MA 02451 (BGM).